Skip to content
PodParley
Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term episode artwork

EPISODE · Apr 23, 2026 · 41 MIN

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

from Off-Target Effects with Matt Gline · host BiotechTV

He and Matt talk about portfolio construction, and the dynamics of taking on the right capital structure throughout different phases of a company's lifecycle. Neil shares early learnings from the commercial launch of Attruby, how being a commercial stage company can impact culture, and why he created the early-stage R&D focused sister company Gondola. Plus, discussing talent, intellectual property, and more.

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

Ready to play

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

0:00 41:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off-Target Effects with Matt Gline?

This episode is 41 minutes long.

When was this Off-Target Effects with Matt Gline episode published?

This episode was published on April 23, 2026.

Can I download this Off-Target Effects with Matt Gline episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!